Bank of New York Mellon’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Bank of New York Mellon's PFE Position: Q2 2026 in Review
Bank of New York Mellon increased its Pfizer (PFE) stake by 7.4% in Q2 2026, buying an estimated $105M and bringing the position to 57,879,546 shares worth $1.39B. The position accounts for 0.23% of the portfolio, ranked #70.
Bank of New York Mellon first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.18B in Q1 2015. 2,239 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Bank of New York Mellon held 57,879,546 shares of Pfizer worth $1.39B as of Q2 2026.
- Bank of New York Mellon bought 3,999,646 Pfizer shares in Q2 2026, an estimated $105M.
- Pfizer made up 0.23% of Bank of New York Mellon's portfolio in Q2 2026, its #70 holding.
- Bank of New York Mellon first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Bank of New York Mellon's Pfizer position peaked at $4.18B in Q1 2015.
- 2,239 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.